1. Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, Mattfeldt T, Tepsic D, Bunjes D, Mottaghy FM, Krause BJ, Neumaier B, Döhner H, Möller P, Reske SN. Molecular Imaging of Proliferation in Malignant Lymphoma. Cancer Res. 2006; 66:11055-11061.
  2. Glatting G, Reske SN. Determination of the immunoreactivity of radiolabeled monoclonal antibodies: A theoretical analysis. Cancer Biother. Radiopharm. 2006; 21:15-21.
  3. Glatting G, Müller M, Koop B, Hohl K, Friesen C, Neumaier B, Berrie E, Bird P, Hale G, Blumstein NM, Waldmann H, Bunjes D, Reske SN. Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia. J. Nucl. Med. 2006; 47:1335-1341.
  4. Glatting G, Kull T, Blumstein NM, Bunjes D, Neumaier B, Buck AK, Reske SN. Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i. Nuklearmedizin 2006; 45:134-138.
  5. Glatting G, Landmann M, Wunderlich A, Kull T, Mottaghy FM, Reske SN. Internal radionuclide therapy: Software for treatment planning using tomographic data. Nuklearmedizin 2006; 45:269-272.
  6. Glatting G. Nuklearmedizin: Physik & Technik. In:Molekulare Bildgebung. Berlin: DGMP, 2006; 19-24.
  7. Glatting G. Einführung in die Kompartiment-Analyse. In:Molekulare Bildgebung. Berlin: DGMP, 2006; 27-30.
  8. Golaszewski SM, Siedentopf CM, Koppelstaetter F, Fend M, Ischebeck A, Gonzalez-Felipe V, Haala I, Struhal W, Mottaghy FM, Gallasch E, Felber SR, Gerstenbrand F. Human brain structures related to plantar vibrotactile stimulation: a functional magnetic resonance imaging study. Neuroimage 2006; 29:923-929.
  9. Krause BJ, Hautzel H, Schmidt D, Flüß MO, Poeppel TD, Müller HW, Halsband U, Mottaghy FM. Learning related interactions among neuronal systems involved in memory processes. J. Physiol. - Paris 2006; 99:318-332.
  10. Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, Schumann C, Mottaghy FM, Hombach V, Reske SN. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. J. Internal Med. 2006; 260:545-550.
  11. Krüger S, Kropf C, Wibmer T, Pauls S, Mottaghy FM, Schumann C, Hombach V. Erdheim-Chester-Erkrankung: seltene Ursache einer interstitiellen Lungenerkrankung. Med. Klin. 2006; 101:573-576.
  12. Mottaghy FM. Interfering with working memory in humans. Neuroscience 2006; 139:85-90.
  13. Mottaghy FM, Willmes K, Horwitz B, Muller HW, Krause BJ, Sturm W. Systems level modeling of a neuronal network subserving intrinsic alertness. Neuroimage 2006; 29:225-233.
  14. Mottaghy FM, Reske SN. Functional imaging of neuroendocrine tumours with PET. Pituitary 2006; 9:237-242.
  15. Mottaghy FM, Sparing S, Töpper R. Enhancing picture naming with transcranial magnetic stimulation. Behav. Neurol. 2006; 17:177-186.
  16. Reske SN, Deisenhofer S. Is 3'-deoxy-3'-18F-fluorothymidine (FLT) a better marker for tumor response than 18F-fluorodeoxyglucose (FDG)? Eur. J. Nucl. Med. Mol. Imaging 2006; 33:S38-S43.
  17. Reske SN, Blumstein NM, Glatting G. Weiterentwicklung der PET und des PET/CT beim Prostatakarzinom [Advancement of PET and PET/CT in prostate carcinoma.]. Urologe A 2006; 45:707-714.
  18. Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, Möller P, Glatting G, Perner S. Imaging Prostate Cancer with 11C-Choline PET/CT. J. Nucl. Med. 2006; 47:1249-1254.
  19. Reske SN. PET Assessment of Lymphoma: Beyond 18F-Fluorodeoxyglucose. PET Clinics 2006; 1:275-281.
  20. Reske SN, Blumstein NM, Glatting G. PET und PET/CT in der Rezidivdiagnostik des Prostata-Karzinoms [PET and PET/CT in relapsing prostate carcinoma]. Urologe A 2006; 45:1240-1250.
  21. Schmid M, Neumaier B, Vogg AT, Wczasek K, Friesen C, Mottaghy FM, Buck AK, Reske SN. Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog. Nucl. Med. Biol. 2006; 33:359-366.
  22. Uttner I, Mottaghy FM, Schreiber H, Riecker A, Ludolph AC, Kassubek J. Primary progressive aphasia accompanied by environmental sound agnosia: A neuropsychological, MRI and PET study. Psychiatry Res. 2006; 146:191-197.
  23. Wöhrle J, Krause BJ, Nusser T, Kochs M, Höher M. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy. Cardiovasc. Revasc. Med. 2006; 7:2-6.
  24. Wöhrle J, Krause BJ, Nusser T, Mottaghy FM, Habig T, Kochs M, Kotzerke J, Reske SN, Hombach V, Höher M. Intracoronary ß-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries  and venous bypass grafts. Eur. J. Nucl. Med. Mol. Imaging 2006; 33:1314-1320.
  25. Zenz T, Schlenk RF, Glatting G, Neumaier B, Blumstein N, Buchmann I, von Harsdorf S, Ringhoffer M, Wiesneth M, Keller F, Kotzerke J, Rottinger E, Stilgenbauer S, Dohner H, Reske SN, Bunjes D. Bone Marrow Transplantation Nephropathy after an Intensified Conditioning Regimen with Radioimmunotherapy and Allogeneic Stem Cell Transplantation. J. Nucl. Med. 2006; 47:278-286.
  26. Zenz T, Glatting G, Schlenk RF, Buchmann I, Döhner H, Reske SN, Bunjes D. Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study. Haematologica 2006; 91:285-286.